Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients

HR Wardill, KR Secombe, RV Bryant, MD Hazenberg… - …, 2019 - thelancet.com
FMT has gained enormous momentum in the treatment of acute inflammatory and infectious
diseases. Despite an encouraging safety profile, FMT has been met with caution in the …

Optimizing symptom control in children and adolescents with cancer

LL Dupuis, S Cook, PD Robinson, D Tomlinson… - Pediatric …, 2019 - nature.com
There is growing recognition of the degree to which symptoms negatively impact on children
receiving cancer treatments. A recent study described that almost all inpatient pediatric …

Plasmid-mediated metronidazole resistance in Clostridioides difficile

IM Boekhoud, BVH Hornung, E Sevilla… - Nature …, 2020 - nature.com
Metronidazole was until recently used as a first-line treatment for potentially life-threatening
Clostridioides difficile (CD) infection. Although cases of metronidazole resistance have been …

Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: a systematic review

A Pession, D Zama, E Muratore, D Leardini… - Journal of Personalized …, 2021 - mdpi.com
The disruption of gut microbiota eubiosis has been linked to major complications in
allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Various strategies …

[HTML][HTML] Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan

KS Wu, LS Syue, A Cheng, TY Yen, HM Chen… - Journal of Microbiology …, 2020 - Elsevier
Clostridioides difficile infection (CDI) is a major enteric disease associated with antibiotic
use and a leading cause of hospital-acquired infections worldwide. This is the first guideline …

[HTML][HTML] Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients

GM Haeusler, T Lehrnbecher, PKA Agyeman… - European Journal of …, 2022 - Elsevier
Abstract Background Epidemiology of Clostridioides difficile infection (CDI) in paediatric
cancer patients is uncertain. The primary objective was to describe the prevalence of CDI …

Oral vancomycin as secondary prophylaxis for Clostridioides difficile infection

H Bao, J Lighter, Y Dubrovskaya, C Merchan… - …, 2021 - publications.aap.org
OBJECTIVES Secondary oral vancomycin prophylaxis (OVP) has been used in adults with a
history of Clostridioides difficile infection (CDI) while receiving systemic antibiotics to prevent …

Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections

GDE Cuvelier, K Paulson… - Transplant Infectious …, 2023 - Wiley Online Library
Background Infectious disease physicians may be asked to evaluate and manage a variety
of infections in immunocompromised hosts undergoing hematopoietic cell transplant (HCT) …

Immune signatures, testing, and management of febrile neutropenia in pediatric cancer patients

K Bochennek, M Hogardt… - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction Infectious complications, particularly invasive bacterial and fungal infections,
are still a major cause of morbidity in pediatric cancer patients and are associated with …

[HTML][HTML] All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma

S Wang, J Liu, H Wu, A Jiang, K Zhao… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
Objective Local recurrence of hepatocellular carcinoma (HCC) after radiofrequency ablation
(RFA) treatment remains a serious problem. Tumor-initiating cells (TICs) are thought to be …